Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cullen/Frost Bankers | CFR | Jan 21, 2025 | 142.60 | -0.41 |
Cullinan Therapeutics | CGEM | Jan 21, 2025 | 10.42 | +1.56 |
Culp | CULP | Jan 21, 2025 | 5.45 | -0.37 |
Cumberland Pharmaceuticals | CPIX | Jan 21, 2025 | 2.43 | -3.95 |
Cummins | CMI | Jan 21, 2025 | 367.17 | +0.23 |
Cumulus Media A | CMLS | Jan 21, 2025 | 0.82 | -2.88 |
Curbline Properties | CURB | Jan 21, 2025 | 23.66 | +0.51 |
Curevac N.V. | CVAC | Jan 21, 2025 | 4.14 | +0.98 |
CuriosityStream | CURI | Jan 21, 2025 | 2.09 | +1.46 |
Curis | CRIS | Jan 21, 2025 | 3.43 | +4.26 |
CURRENC Group | CURR | Jan 21, 2025 | 2.13 | -4.05 |
Curtiss-Wright | CW | Jan 21, 2025 | 382.18 | +4.16 |
Cushing Mlp & Infrastructure Total Return Fund | SRV | Jan 21, 2025 | 49.50 | +1.16 |
Cushman & Wakefield | CWK | Jan 21, 2025 | 13.67 | +2.63 |
Custom Truck One Source | CTOS | Jan 21, 2025 | 5.02 | +5.46 |
Customers Bancorp | CUBI | Jan 21, 2025 | 50.67 | +1.34 |
Customers Bancorp E Pref | CUBI-E | Jan 21, 2025 | 25.93 | +0.28 |
Customers Bancorp F Pref | CUBI-F | Jan 21, 2025 | 25.55 | +0.37 |
Cutera | CUTR | Jan 21, 2025 | 0.49 | +2.73 |
CVB Financial | CVBF | Jan 21, 2025 | 20.75 | +1.07 |
CVD Equipment | CVV | Jan 21, 2025 | 3.75 | -0.79 |
CVR Energy | CVI | Jan 21, 2025 | 21.35 | +1.28 |
Cvr Partners LP Unit | UAN | Jan 21, 2025 | 82.97 | -1.16 |
CVRx | CVRX | Jan 21, 2025 | 18.40 | +4.43 |
CVS Health | CVS | Jan 21, 2025 | 53.15 | +1.01 |
CXApp A | CXAI | Jan 21, 2025 | 1.74 | -2.79 |
CyberArk Software | CYBR | Jan 21, 2025 | 355.58 | +0.95 |
Cybin | CYBN | Jan 21, 2025 | 9.62 | +5.37 |
Cyclacel Pharmaceuticals | CYCC | Jan 21, 2025 | 0.36 | +1.15 |
Cyclacel Pharmaceuticals Pref | CYCCP | Jan 21, 2025 | 8.00 | -5.88 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.